3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Carcinoma, Renal Cell
2
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Skin Neoplasms
1
Rectal Diseases
1
Pilonidal Sinus
1
Pancreatic Neoplasms
1
Pain, Postoperative
1
Hemorrhage
1
Endometriosis
1
Dysplastic Nevus Syndrome
1
Diverticulitis
1
Crohn Disease
1
Constipation
1
Colonic Diseases
1
Colitis, Ulcerative
1
Carcinoma, Squamous Cell
1
Carcinoma, Basal Cell
1
Bile Duct Neoplasms
1
Interventions
HhAntag691
14
Biopsy
8
Imiquimod
7
Aminolevulinic Acid
7
sonidegib
6
Tomography, Optical Coherence
6
Surgical Procedures, Operative
6
Photochemotherapy
6
Mohs Surgery
6
1-phenyl-3,3-dimethyltriazene
6
Radiotherapy
5
Itraconazole
5
Nivolumab
4
Microscopy, Confocal
4
Curettage
4
pembrolizumab
3
methyl 5-aminolevulinate
3
cemiplimab
3
Standard of Care
3
Niacinamide
3
tazarotene
2
relatlimab
2
X-Rays
2
Watchful Waiting
2
Specimen Handling
2
Observation
2
Magnetic Resonance Spectroscopy
2
Laser Therapy
2
Gene Expression Profiling
2
Eflornithine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Carcinoma, Basal Cell
×
Sutures
×
Clear all
NCT00586040
2009-04-10
PTB
Massachusetts General Hospital
Phase 2
Completed
40 enrolled